Compare RVTY & GTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVTY | GTLS |
|---|---|---|
| Founded | 1937 | 1859 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Metal Fabrications |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 9.3B |
| IPO Year | 1994 | N/A |
| Metric | RVTY | GTLS |
|---|---|---|
| Price | $92.22 | $206.93 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 11 |
| Target Price | $113.00 | ★ $203.22 |
| AVG Volume (30 Days) | ★ 1.3M | 1.1M |
| Earning Date | 04-27-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.29% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.07 | N/A |
| Revenue | ★ $3,311,822,000.00 | N/A |
| Revenue This Year | $6.34 | $8.33 |
| Revenue Next Year | $5.10 | $11.45 |
| P/E Ratio | ★ $46.38 | $240.25 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $81.36 | $104.60 |
| 52 Week High | $120.39 | $208.24 |
| Indicator | RVTY | GTLS |
|---|---|---|
| Relative Strength Index (RSI) | 34.18 | 46.32 |
| Support Level | $88.56 | $206.71 |
| Resistance Level | $95.99 | $207.69 |
| Average True Range (ATR) | 3.21 | 0.41 |
| MACD | -0.46 | -0.06 |
| Stochastic Oscillator | 0.47 | 25.77 |
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.